ArticleBlood neoplasia2024

A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy.

Elizabeth A Brem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.